Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 30 Jan 25 6-K Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Targetâ„¢ (T&T) Intranasal Drug Delivery Platform
- 23 Jan 25 6-K Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
- 21 Jan 25 6-K Report of Foreign Private Issuer
- 30 Dec 24 6-K Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
- 19 Dec 24 6-K Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
- 13 Dec 24 6-K Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance
- 2 Dec 24 6-K Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
- 30 Oct 24 6-K Report of Foreign Private Issuer
-
28 Oct 24 CERT Certification of approval for exchange listing
- 21 Oct 24 8-A12B Registration of securities on exchange
External links